KHAN A.N.; CHOWDHURY A.; KARULKAR A.; JAISWAL A.K.; BANIK A.; ASIJA S.; PURWAR R.
(Frontiers Media S.A., 2022)
Chimeric antigen receptor t cell (car-t) therapy demonstrated remarkable success in long-term remission of cancers and other autoimmune diseases. Currently, six products (kymriah, yescarta, tecartus, breyanzi, abecma, and ...